National Cancer Institute
U.S. National Institutes of Health | www.cancer.gov

NCI Home
Cancer Topics
Clinical Trials
Cancer Statistics
Research & Funding
News
About NCI
Hairy Cell Leukemia Treatment (PDQ®)
Patient Version   Health Professional Version   En español   Last Modified: 10/31/2008



Purpose of This PDQ Summary






General Information About Hairy Cell Leukemia






Stage Information for Hairy Cell Leukemia






Treatment Option Overview






Treatment for Hairy Cell Leukemia






Relapsed or Refractory Hairy Cell Leukemia






Get More Information From NCI






Changes to This Summary (10/31/2008)






More Information



Page Options
Print This Page
Print Entire Document
View Entire Document
E-Mail This Document
Quick Links
Director's Corner

Dictionary of Cancer Terms

NCI Drug Dictionary

Funding Opportunities

NCI Publications

Advisory Boards and Groups

Science Serving People

Español
Quit Smoking Today
NCI Highlights
The Nation's Investment in Cancer Research FY 2010

Report to Nation Finds Declines in Cancer Incidence, Death Rates

High Dose Chemotherapy Prolongs Survival for Leukemia

Prostate Cancer Study Shows No Benefit for Selenium, Vitamin E
General Information About Hairy Cell Leukemia

Hairy cell leukemia is a chronic lymphoproliferative disorder that is easily controlled. The decision to treat is based on symptomatic cytopenias, massive splenomegaly, or the presence of other complications. About 10% of all patients will never require therapy.

Back to Top

< Previous Section  |  Next Section >


A Service of the National Cancer Institute
Department of Health and Human Services National Institutes of Health USA.gov